表紙
市場調查報告書

綠茶萃取物 (EGCG)的全球市場:在醫學保健食品、化妝品、醫藥品領域的市場機會的評估

Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H1 2019

出版商 GervanoRA Data Services LLP 商品編碼 833000
出版日期 內容資訊 英文 103 Pages
訂單完成後即時交付
價格
綠茶萃取物 (EGCG)的全球市場:在醫學保健食品、化妝品、醫藥品領域的市場機會的評估 Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H1 2019
出版日期: 2019年04月26日內容資訊: 英文 103 Pages
簡介

本報告提供全球綠茶萃取物 - EGCG (表沒食子兒茶素沒食子酸酯) 等 - 的市場相關分析,產品概要、成分和開採技術,主要的應用領域,各用途的市場趨勢預測,目前臨床實驗的發展情形,主要企業的簡介和SWOT分析等資訊彙整,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

  • 分析概要
  • 近來的市場主要動向
  • 主要的分析結果
    • 推動市場要素
    • 阻礙市場要素
    • 未滿足需求、市場機會

第3章 綠茶萃取物概要

  • 全般的考慮事項
    • 綠茶萃取物的概要
    • 綠茶萃取物的組成結構
    • 綠茶萃取物產業概要 - 未來展望

第4章 綠茶萃取物的開採技術

  • 直接茶萃取物開採技術的開發
  • 直接茶萃取物開採技術的趨勢 - 現狀與未來展望

第5章 綠茶萃取物的市場機會的評估 (各最終用途/各用途)

  • 綠茶萃取物:在醫學保健食品領域的市場機會
    • 補充品錠劑
    • 機能性食品
    • 機能飲料
  • 綠茶萃取物:在化妝品領域的市場機會
    • 個人保養用品
    • 美容補充品
  • 綠茶萃取物:在醫藥品領域的市場機會
    • 各症狀的利用機會

第6章 臨床實驗趨勢

  • 醫藥品方面臨床實驗趨勢
  • 醫學保健食品方面臨床實驗趨勢
  • 化妝品方面臨床實驗趨勢

第7章 競爭趨勢:概要

  • 現有企業和SWOT分析

第8章 簡稱一覽

目錄
Product Code: GERPH1312

The ‘Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H1 2019’ report provides in-depth insights with respect to the three major applications and is built to provide strategically important competitor information, analytics, and insights to formulate effective counter research and development strategies. The report offers comprehensive analytics on GTE competitive space by covering nutraceuticals, cosmetics and pharmaceutical segments to assess the unmet needs, drivers, restrains and opportunities.

The following segments provide detailed analytics covering the overall GTE competitive space:

  • Key Events in GTE competitive space
  • Major Drivers, Restraints and Unmet Needs & Opportunities
  • GTE Industry overview
  • Developments and Trends in its Extraction Technologies
  • End Use Opportunity Assessment
  • Clinical Developments
  • Competitive Landscape of Companies
  • Key Companies SWOT Analysis

Report is concentrated more on providing the future favorable opportunities and growth that can be expected in the Green Tea Extract (GTE) market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. METHODOLOGY
  • 1.3. ABOUT US: GERVANORA DATA SERVICES

2. EXECUTIVE SUMMARY

  • 2.1. REPORT SUMMARY
  • 2.2. KEY EVENTS IN GREEN TEA EXTRACT COMPETITIVE SPACE- RECENT DEVELOPMENTS
    • 2.2.1. KEY EVENTS IN THE PHARMACEUTICAL DOMAIN
    • 2.2.2. KEY EVENTS IN THE NUTRACEUTICAL DOMAIN
    • 2.2.3. KEY EVENTS IN THE COSMETICS DOMAIN
  • 2.3. MAJOR FINDINGS
    • 2.3.1. DRIVERS
    • 2.3.2. RESTRAINTS
    • 2.3.3. UNMET NEEDS AND OPPORTUNITIES

3. GREEN TEA EXTRACT OVERVIEW

  • 3.1. GENERAL CONSIDERATIONS
    • 3.1.1. BRIEF INTRODUCTION OF GREEN TEA EXTRACT
    • 3.1.2. COMPOSITION OF GREEN TEA EXTRACT
      • 3.1.2.1 EC (EPICATECHIN)
      • 3.1.2.2 EGC (EPIGALLOCATECHIN)
      • 3.1.2.3 ECG (EPICATECHIN GALLATE)
      • 3.1.2.4 EGCG (EPIGALLOCATECHIN-3-GALLATE)
      • 3.1.2.5 OTHER POLYPHENOLS
      • 3.1.2.6 CAFFEINE
    • 3.1.3. OVERVIEW OF GREEN TEA EXTRACT INDUSTRY - FUTURE PERSPECTIVES

4. GREEN TEA EXTRACT TECHNOLOGIES

  • 4.1. DEVELOPMENTS IN GREEN TEA EXTRACTION TECHNOLOGIES
  • 4.2. TRENDS IN GREEN TEA EXTRACTION TECHNOLOGIES- CURRENT STATUS AND FUTURE PROSPECTS

5. GREEN TEA EXTRACT OPPORTUNITIES ASSESSMENT (END USE OR APPLICATION SEGMENT)

  • 5.1. GREEN TEA EXTRACT OPPORTUNITIES IN NUTRACEUTICAL
    • 5.1.1. EGCG APPLICATIONS IN NUTRACEUTICAL
      • 5.1.1.1 DIETARY SUPPLEMENTAL PILLS
      • 5.1.1.2 FUNCTIONAL FOODS
      • 5.1.1.3 ENERGY DRINKS
  • 5.2. GREEN TEA EXTRACT OPPORTUNITIES IN COSMETICS
    • 5.2.1. EGCG APPLICATIONS IN COSMETICS
      • 5.2.1.1 PERSONAL CARE PRODUCTS
      • 5.2.1.2. BEAUTY SUPPLEMENTS
  • 5.3. GREEN TEA EXTRACT OPPORTUNITIES IN PHARMACEUTICALS
    • 5.3.1. EGCG APPLICATIONS IN PHARMACEUTICALS
      • 5.3.1.1 INDICATION WISE APPLICATIONS

5.3.1.1.1 APPLICATIONS IN ONCOLOGY

5.3.1.1.2 APPLICATIONS IN CARDIOVASCULAR

5.3.1.1.3 APPLICATIONS IN METABOLIC DISORDERS

5.3.1.1.4 APPLICATIONS IN INFLAMMATORY SKIN DISEASES

5.3.1.1.5 APPLICATIONS IN NEURODEGENERATIVE DISEASES

5.3.1.1.6 APPLICATIONS IN OBESITY

6. CLINICAL DEVELOPMENTS

  • 6.1. CLINICAL DEVELOPMENTS IN PHARMACEUTICALS
  • 6.2. CLINICAL DEVELOPMENTS IN NUTRACEUTICALS
  • 6.3. CLINICAL DEVELOPMENTS IN COSMETICS

7. OVERVIEW OF COMPETITIVE SEGMENT

  • 7.1. ESTABLISHED COMPANIES AND SWOT
    • 7.1.1. INDENA S.P.A
    • 7.1.2. TAIYO INTERNATIONAL
    • 7.1.3. BLUE CALIFORNIA
    • 7.1.4. HUNAN SUNFULL BIO-TECH CO. LTD
    • 7.1.5. TATE AND LYLE
    • 7.1.6. ROYAL DSM
    • 7.1.7. APPLIED FOOD SCIENCES, INC

8. ABBREVIATIONS

LIST OF FIGURES

  • FIGURE 01: PAST EVENTS IN THE GTE PHARMACEUTICAL MARKET SPACE, 2006 TILL DATE
  • FIGURE 02: FUTURE ESTIMATED PIPELINE MOLECULE APPROVALS
  • FIGURE 03: KEY EVENTS IN THE NUTRACEUTICAL MARKET SPACE
  • FIGURE 04: KEY EVENTS IN THE COSMETICS MARKET SPACE
  • FIGURE 05: TRADITIONAL GREEN TEA EXTRACTION TECHNIQUES
  • FIGURE 06: ADVANCED GREEN TEA EXTRACTION TECHNOLOGIES
  • FIGURE 07: EGCG OPPORTUNITIES IN COSMETICS
  • FIGURE 08: INDENA MARKET OVERVIEW, GLOBAL
  • FIGURE 09: ANNUAL REVENUES (FY ENDED MARCH IN $M), TATE AND LYLE
  • FIGURE 10: ANNUAL REVENUES BY BUSINESS SEGMENTS, TATA AND LYLE
  • FIGURE 11: ANNUAL REVENUES SHARE OF BUSINESS SEGMENTS, DSM
  • FIGURE 12: DSM SALES BY DESTINATION REGIONS

LIST OF TABLES

  • TABLE 01: UNIVERSITIES AND INSTITUTES IN GTE RESEARCH
  • TABLE 02: EGCG OPPORTUNITIES IN OBESITY CONTROL
  • TABLE 03: EGCG OPPORTUNITIES IN ONCOLOGY
  • TABLE 04: EGCG OPPORTUNITIES IN DIABETES
  • TABLE 05: EGCG OPPORTUNITIES IN NEURODEGENERATIVE DISEASES
  • TABLE 06: EGCG OPPORTUNITIES IN LIVER DISEASES
  • TABLE 07: ASSESSMENT OF STUDIES FOR EGCG OPPORTUNITIES IN NUTRACEUTICALS
  • TABLE 08: OPPORTUNITY FINDINGS OF EGCG IN COSMETICS
  • TABLE 09: EGCG APPLICATIONS IN ONCOLOGY
  • TABLE 10: EGCG APPLICATIONS IN CARDIOVASCULAR DISEASES
  • TABLE 11: EGCG APPLICATIONS IN METABOLIC DISORDERS
  • TABLE 12: EGCG APPLICATIONS IN INFLAMMATROY SKIN DISEASES
  • TABLE 13: EGCG APPLICATIONS IN NEURODEGENRATIVE DISEASES
  • TABLE 14: EGCG APPLICATIONS IN OBESITY
  • TABLE 15: CLINICAL TRIALS IN PHARMACEUTICALS
  • TABLE 16: CLINICAL TRIALS IN NUTRACEUTICALS